Outside actors already moving: management's forward story is carried by at least two independent external parties whose
The model's full reasoning — Q3 2023 call → NOWe need to answer YES or NO based on the criteria. The question asks: "On this call, when management explains why the company's business is about to be meaningfully larger, is that explanation carried primarily by the ALREADY-TAKEN ACTIONS OF EXTERNAL PARTIES — and are there AT LEAST TWO SEPARATE such external parties or party groups whose actions management describes as already underway, with the resulting business only beginning to appear in the reported results?" We need to check the transcript for management's explanation of growth. The call discusses Q3 2023 results, transformation, and future outlook. Management talks about the transformation plan, gross margins, cash burn, and then discusses Alzheimer's disease testing, partnerships, and new products. Key points: Management mentions a new agreement with Johnson & Johnson Innovative Medicines for a P-tau217 test. Also mentions Lilly's presentation at CTAD using Simoa platform. Also mentions VUMC and Amsterdam studies. But the question is about why the business is about to be meaningfully larger. Management talks about the transformation being complete, new assays rolling off production line in January, and then discusses the Alzheimer's market, partnerships, and the potential for growth. But the question specifically asks: "when management explains why the company's business is about to be meaningfully larger, is that explanation carried primarily by the ALREADY-TAKEN ACTIONS OF EXTERNAL PARTIES?" So we need to see if management attributes growth to external parties' already-taken actions, like customers, partners, etc., and if there are at least two separate such parties. In the transcript, management mentions the J&J agreement, Lilly's data, and also mentions that they are working with VUMC and others. But are these described as already-taken actions that will lead to meaningful growth? The J&J agreement is signed, and they launched a test. That is an external party action. Lilly presented data using Simoa, which is also an external party action. But are these described as already underway and leading to business that is only beginning to appear? Management says: "we signed a new agreement with Johnson & Johnson Innovative Medicines and launched the Lucent AD P-tau217 blood based biomarker test" - that is an action. Also, they mention Lilly's presentation, but that is more about validation.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| SITM | SiTime Corporation | Q2 2023 | 2023-08-02 | C+ |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| MEC | Mayville Engineering Company, Inc. | Q3 2022 | 2022-11-05 | B+ |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| CPK | Chesapeake Utilities Corporation | Q3 2017 | 2017-11-10 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
| HPP | Hudson Pacific Properties, Inc. | Q4 2015 | 2016-02-25 | C |
MEC · Q3 2022 → YESThe question is about whether management explains why the company's business is about to be meaningfully larger based on already-taken actions of external parties, with at least two separate such part...YES The transcript shows management attributing meaningful future growth primarily to external customer actions already taken: specific awards and wins (e.g., large family of parts for electric side-by-side with full 2023 launch; high-value takeover project for ag customer; reshoring project closed for commercial vehicle customer starting early 2023; 2023 production ramp at Hazel Park facility; incremental business from light-duty truck platform). These are concrete, past-tense commitments from distinct customers (existing side-by-side customer, ag customer, commercial vehicle customer, light-duty truck engine manufacturer, new industrial infrastructure customer), with volumes and ramps explicitly described as beginning in 202 3 and continuing into coming quarters.
EVGO · Q2 2022 → YESThe question is about whether management explains why the business is about to be meaningfully larger based on already-taken actions of external parties, with at least two separate such parties, and t...YES The transcript shows management framing the company's growth as driven by external parties' already-completed actions: the GM-Pilot partnership (signed and announced, with EVgo to procure/construct/operate/maintain up to 2,000 stalls and 500 locations, delivering near-term revenue and contracted cash flows), the 2023 Cadillac LYRIQ charging offer (commercial agreement signed), the Philadelphia municipal fleet partnership (announced and operational), the GSA BPA award (five-year blanket purchase agreement now in place for federal agencies), and the California Energy Commission grant (selected for $3.6 million to build fast charging).
PRIM · Q2 2018 → YESThe question is about whether management explains why the business is about to be meaningfully larger based on already-taken actions of at least two separate external parties, and the reported results...YES The transcript shows management framing the business as about to become meaningfully larger primarily through external parties' already-completed actions: (1) the Willbros acquisition closed June 1, 2018, with Willbros now contributing $61 million revenue and $6.8 million gross profit in June alone (one month 2018 results), and (2) three separate major customers—previously hesitant due to Willbros' prior financial concerns—have now awarded work to the newly acquired T&D Group, with the largest MSA award announced and two additional awards leaking out, all within the first two months post-acquisition.